Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GRAMD3 | CTRPv2 | pan-cancer | AAC | -0.23 | 8e-13 |
mRNA | CD63 | CTRPv2 | pan-cancer | AAC | -0.26 | 2e-12 |
mRNA | PRPF38A | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-12 |
mRNA | MCM2 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-12 |
mRNA | ELAVL1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-12 |
mRNA | KLHL8 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-12 |
mRNA | ARHGAP19 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-12 |
mRNA | IRAK1BP1 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-12 |
mRNA | ILF3 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-12 |
mRNA | TFAP4 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-12 |